Tenecteplase (TNK) for Loculated Pleural Effusions in Patients With Malignancy
NCT01580618
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
TERMINATED
Status
20
Enrollment
OTHER
Sponsor class
Stopped
Unable to accrue patients at a reasonable rate
Conditions
Pleural Effusion
Interventions
DRUG:
normal saline
DRUG:
TNK (Tenecteplase)
Sponsor
Kaiser Permanente
Collaborators
[object Object]